STUB1 and COVID-19: There is growing evidence supporting the role of CHIP mutations in altered immune function through effector cells such as monocytes/macrophages and their dysregulated cytokine/chemokine expression18–21, which largely shares the immunopathogenic signatures of severe COVID-19.